Jorge Malouf

Jorge Malouf

Hospital de la Santa Creu i Sant Pau - Barcelona / Spain
Others
AD Scientific Index ID: 4474628
Hospital of the Holy Cross and Sant Pau
person_outline Jorge Malouf's MOST POPULAR ARTICLES
1-) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension The lancet Diabetes & endocrinology 5 (7), 513-523, 2017
2-) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised … The Lancet 391 (10117), 230-240, 2018
3-) Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis Jama 326 (6), 499-518, 2021
4-) Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open … The Lancet 390 (10102), 1585-1594, 2017
5-) Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates The Journal of Clinical Endocrinology & Metabolism 101 (8), 3163-3170, 2016